Korean J Urol. 2009 Feb;50(2):195-198. Korean.
Published online Feb 25, 2009.
Copyright © The Korean Urological Association, 2009
Case Report

Familial Prostate Cancer in Three Brothers

Sung Han Kim,1 Kang Su Cho, Kyung Seok Han, Jae Young Joung, Ho Kyung Seo, Jinsoo Chung, Hee Ok Pak,2 Weon Seo Park,3 and Kang Hyun Lee
    • Urologic Oncology Clinic, National Cancer Center, Goyang, Korea.
    • 1Department of Urology, Seoul National University College of Medicine, Seoul, Korea.
    • 2Gachon University of Medicine and Science, Incheon, Korea.
    • 3Department of Pathology, National Cancer Center, Goyang, Korea.
Received July 24, 2008; Accepted October 13, 2008.

Abstract

We treated a family of 3 brothers with prostate cancer, which is the first report of familial prostate cancer in Korea. Prostate cancer was diagnosed in the first brother with a prostate-specific antigen (PSA) level of 12.70 ng/ml of at the age of 68 years. He underwent a radical retropubic prostatectomy (RRP); the cancer was pathologically staged to T2cN1Mo. He received adjuvant hormonal therapy postoperatively. Three years later, prostate cancer was diagnosed in the third brother at the age of 61 years with a high PSA level of 4.45 ng/ml. He underwent RRP, which revealed the pathological stage to be T2cN0M0. Three months later, the second brother, who had visited our hospital for lower urinary tract symptoms and for a PSA screening test was diagnosed with prostate cancer at the age of 60 years (PSA level of 3.96 ng/ml). He also underwent RRP, and his cancer was staged pathologically as T2cN0M0.

Keywords
Prostatic neoplasms; Siblings

Figures

Fig. 1
Three brothers' familial pedigree.

Tables

Table 1
Patients' characteristics

Table 2
Molecular genetic analysis of BRCA2 gene mutation by PCR and direct sezuencing in genomic DNA isolated from peripheral blood leukocytes

References

    1. Carter BS, Bova GS, Beauty TH, Steinberg GD, Childs B, Isaacs WB, et al. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993;150:797–802.
    1. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990;17:337–347.
    1. Spitz MR, Currier RD, Fueger JJ, Babaian RJ, Newell GR. Familial patterns of prostate cancer: a case-control analysis. J Urol 1991;146:1305–1307.
    1. Klein EA, Platz EA, Thomson IM. Epidemiology, etiology, and prevention of prostate cancer. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 9th ed. Philadelphia: Saunders; 2007. pp. 2857-2858.
    1. Woolf CM. An investigation of the familial aspects of carcinoma of the prostate. Cancer 1960;13:739–744.
    1. Bratt O. Hereditary prostate cancer: clinical aspects. J Urol 2002;168:906–913.
    1. Eeles RA, Dearnaley DP, Ardern-Jones A, Shearer RJ, Easton DF, Ford D, et al. Familial prostate cancer: the evidence and the Cancer Research Campaign/British Prostate Group (CRC/BPG) UK Familial Prostate Cancer Study. Br J Urol 1997;79 Suppl 1:8–14.
    1. Lee SE. Diagnosis of prostate cancer. Korean J Urol 2004;45:197–208.
    1. Hwang KH, Chung MK. Screening for prostatic cancers in Korean. Korean J Urol 1995;36:1062–1070.
    1. Gillanders EM, Xu J, Chang BL, Lange EM, Wiklund F, Bailey-Wilson JE, et al. Combined genome-wide scan for prostate cancer susceptibility genes. J Natl Cancer Inst 2004;96:1240–1247.

Metrics
Share
Figures

1 / 1

Tables

1 / 2

PERMALINK